1. Home
  2. CDXC
  3. CDXC News

Latest ChromaDex Corporation (CDXC) News on January 3, 2025

The Zacks Analyst Blog Highlights ADMA Biologics, Tarsus Pharmaceuticals, Stoke Therapeutics, Inc. and ChromaDex
CDXC

Zacks

8 days ago

The Zacks Analyst Blog Highlights ADMA Biologics, Tarsus Pharmaceuticals, Stoke Therapeutics, Inc. and ChromaDex

4 Drug, Biotech Stocks Rising More Than 50% in 2024 With Room to Grow
CDXC

Zacks

10 days ago

4 Drug, Biotech Stocks Rising More Than 50% in 2024 With Room to Grow

3 US Growth Companies With High Insider Ownership Expecting Up To 119% Earnings Growth
CDXC

Simply Wall St.

14 days ago

3 US Growth Companies With High Insider Ownership Expecting Up To 119% Earnings Growth

Exploring December 2024's US Undervalued Small Caps With Insider Buying
CDXC

Simply Wall St.

14 days ago

Exploring December 2024's US Undervalued Small Caps With Insider Buying

Even though ChromaDex (NASDAQ:CDXC) has lost US$73m market cap in last 7 days, shareholders are still up 389% over 1 year
CDXC

Simply Wall St.

24 days ago

Even though ChromaDex (NASDAQ:CDXC) has lost US$73m market cap in last 7 days, shareholders are still up 389% over 1 year

ChromaDex Named to the Inc. 2024 Best in Business List in the Health Products Category
CDXC

Business Wire

a month ago

ChromaDex Named to the Inc. 2024 Best in Business List in the Health Products Category

ChromaDex Corporation (CDXC) Hits Fresh High: Is There Still Room to Run?
CDXC

Zacks

a month ago

ChromaDex Corporation (CDXC) Hits Fresh High: Is There Still Room to Run?

3 US Stocks Estimated To Be Trading At Discounts Ranging From 13% To 41%
CDXC

Simply Wall St.

a month ago

3 US Stocks Estimated To Be Trading At Discounts Ranging From 13% To 41%

3 US Growth Companies With Strong Insider Confidence
CDXC

Simply Wall St.

2 months ago

3 US Growth Companies With Strong Insider Confidence

ChromaDex’s Patented Nicotinamide Riboside (NR) Ingredient, Niagen®, Featured as the Hero Ingredient in Longevity.Technology’s Inaugural Longevity Supplement
CDXC

Business Wire

2 months ago

ChromaDex’s Patented Nicotinamide Riboside (NR) Ingredient, Niagen®, Featured as the Hero Ingredient in Longevity.Technology’s Inaugural Longevity Supplement

What Makes ChromaDex (CDXC) a Strong Momentum Stock: Buy Now?
CDXC

Zacks

2 months ago

What Makes ChromaDex (CDXC) a Strong Momentum Stock: Buy Now?

5 Stocks With Recent Price Strength to Tap Wall Street Rally
CDXC

Zacks

2 months ago

5 Stocks With Recent Price Strength to Tap Wall Street Rally

ChromaDex's Pharmaceutical-Grade Niagen® IV Now Accessible at over 200 Restore Hyper Wellness Clinics Nationwide
CDXC

Business Wire

2 months ago

ChromaDex's Pharmaceutical-Grade Niagen® IV Now Accessible at over 200 Restore Hyper Wellness Clinics Nationwide

Shareholders Can Be Confident That ChromaDex's (NASDAQ:CDXC) Earnings Are High Quality
CDXC

Simply Wall St.

2 months ago

Shareholders Can Be Confident That ChromaDex's (NASDAQ:CDXC) Earnings Are High Quality

ChromaDex Corporation (CDXC) Hit a 52 Week High, Can the Run Continue?
CDXC

Zacks

2 months ago

ChromaDex Corporation (CDXC) Hit a 52 Week High, Can the Run Continue?

ChromaDex Third Quarter 2024 Earnings: Beats Expectations
CDXC

Simply Wall St.

2 months ago

ChromaDex Third Quarter 2024 Earnings: Beats Expectations

ChromaDex Corp (CDXC) Q3 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ...
CDXC

GuruFocus.com

2 months ago

ChromaDex Corp (CDXC) Q3 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ...

ChromaDex (CDXC) Beats Q3 Earnings and Revenue Estimates
CDXC

Zacks

2 months ago

ChromaDex (CDXC) Beats Q3 Earnings and Revenue Estimates

CDXC

Associated Press Finance

2 months ago

ChromaDex: Q3 Earnings Snapshot

ChromaDex Corporation Reports Third Quarter 2024 Financial Results
CDXC

Business Wire

2 months ago

ChromaDex Corporation Reports Third Quarter 2024 Financial Results

ChromaDex Corp (CDXC) Q3 2024 Earnings Report Preview: What To Expect
CDXC

GuruFocus.com

2 months ago

ChromaDex Corp (CDXC) Q3 2024 Earnings Report Preview: What To Expect

ChromaDex Gears Up to Report Q3 Earnings: Here's What to Expect
CDXC

Zacks

2 months ago

ChromaDex Gears Up to Report Q3 Earnings: Here's What to Expect

ChromaDex to Report Third Quarter 2024 Financial Results on Thursday, October 31, 2024
CDXC

Business Wire

2 months ago

ChromaDex to Report Third Quarter 2024 Financial Results on Thursday, October 31, 2024

ChromaDex to Report Third Quarter 2024 Financial Results on Thursday, October 31, 2024
CDXC

Business Wire

2 months ago

ChromaDex to Report Third Quarter 2024 Financial Results on Thursday, October 31, 2024

ChromaDex Leads The Charge With 2 Other US Penny Stocks To Watch
CDXC

Simply Wall St.

2 months ago

ChromaDex Leads The Charge With 2 Other US Penny Stocks To Watch

ChromaDex to Participate in the 17th Annual LD Micro Main Event
CDXC

Business Wire

2 months ago

ChromaDex to Participate in the 17th Annual LD Micro Main Event

Are Medical Stocks Lagging ChromaDex (CDXC) This Year?
CDXC

Zacks

3 months ago

Are Medical Stocks Lagging ChromaDex (CDXC) This Year?

3 US Growth Companies Insiders Own With Up To 102% Earnings Growth
CDXC

Simply Wall St.

3 months ago

3 US Growth Companies Insiders Own With Up To 102% Earnings Growth

Yasmeen Nkrumah-Elie, Ph.D., Global Director of External Research at ChromaDex, Honored with the Trailblazing Woman Award by Radicle Science and Council for Responsible Nutrition (CRN)
CDXC

Business Wire

3 months ago

Yasmeen Nkrumah-Elie, Ph.D., Global Director of External Research at ChromaDex, Honored with the Trailblazing Woman Award by Radicle Science and Council for Responsible Nutrition (CRN)

ChromaDex Corp (CDXC) Q2 2024 Earnings Call Highlights: Revenue Growth and Strategic Challenges
CDXC

GuruFocus.com

3 months ago

ChromaDex Corp (CDXC) Q2 2024 Earnings Call Highlights: Revenue Growth and Strategic Challenges

ChromaDex to Participate in a Fireside Chat at the Lytham Partners Fall 2024 Investor Conference
CDXC

Business Wire

3 months ago

ChromaDex to Participate in a Fireside Chat at the Lytham Partners Fall 2024 Investor Conference

Is ChromaDex (CDXC) Stock Outpacing Its Medical Peers This Year?
CDXC

Zacks

3 months ago

Is ChromaDex (CDXC) Stock Outpacing Its Medical Peers This Year?

CDXC

MT Newswires

3 months ago

ChromaDex Appoints Ozan Pamir CFO

ChromaDex Appoints Ozan Pamir as Chief Financial Officer
CDXC

Business Wire

3 months ago

ChromaDex Appoints Ozan Pamir as Chief Financial Officer

3 US Growth Companies With High Insider Ownership
CDXC

Simply Wall St.

4 months ago

3 US Growth Companies With High Insider Ownership

Insiders own 31% of ChromaDex Corporation (NASDAQ:CDXC) shares but retail investors control 42% of the company
CDXC

Simply Wall St.

4 months ago

Insiders own 31% of ChromaDex Corporation (NASDAQ:CDXC) shares but retail investors control 42% of the company

ChromaDex Announces Expansion of Pharmaceutical-Grade Niagen® IV and Injection Offerings to Additional Leading Wellness Clinics
CDXC

Business Wire

4 months ago

ChromaDex Announces Expansion of Pharmaceutical-Grade Niagen® IV and Injection Offerings to Additional Leading Wellness Clinics

ChromaDex Celebrates 25 Years of Innovation and Pioneering NAD+ Research for Healthy Aging Solutions
CDXC

Business Wire

4 months ago

ChromaDex Celebrates 25 Years of Innovation and Pioneering NAD+ Research for Healthy Aging Solutions

ChromaDex to Participate in Renmark’s Virtual Non-Deal Roadshow Series On Thursday, August 29, 2024
CDXC

Business Wire

4 months ago

ChromaDex to Participate in Renmark’s Virtual Non-Deal Roadshow Series On Thursday, August 29, 2024

Is Brainsway (BWAY) Stock Outpacing Its Medical Peers This Year?
CDXC

Zacks

4 months ago

Is Brainsway (BWAY) Stock Outpacing Its Medical Peers This Year?

Top US Growth Companies With High Insider Ownership In August 2024
CDXC

Simply Wall St.

4 months ago

Top US Growth Companies With High Insider Ownership In August 2024

CDXC

MT Newswires

4 months ago

ChromaDex Awarded US Patent for NMNH Salt Form

ChromaDex Secures U.S. Patent for the Composition of Matter of Salt Forms of NMNH (Dihydronicotinamide Mononucleotide), a Precursor to NAD+
CDXC

Business Wire

4 months ago

ChromaDex Secures U.S. Patent for the Composition of Matter of Salt Forms of NMNH (Dihydronicotinamide Mononucleotide), a Precursor to NAD+

ChromaDex (CDXC) Reports Break-Even Earnings for Q2
CDXC

Zacks

5 months ago

ChromaDex (CDXC) Reports Break-Even Earnings for Q2

CDXC

Associated Press Finance

5 months ago

ChromaDex: Q2 Earnings Snapshot

ChromaDex Corporation Reports Second Quarter 2024 Financial Results
CDXC

Business Wire

5 months ago

ChromaDex Corporation Reports Second Quarter 2024 Financial Results

ChromaDex to Present at Canaccord Genuity’s 44th Annual Growth Conference
CDXC

Business Wire

5 months ago

ChromaDex to Present at Canaccord Genuity’s 44th Annual Growth Conference

ChromaDex to Report Second Quarter 2024 Financial Results on Wednesday, August 7, 2024
CDXC

Business Wire

5 months ago

ChromaDex to Report Second Quarter 2024 Financial Results on Wednesday, August 7, 2024

ChromaDex Launches Niagen+ NAD+ Test Kit Available Exclusively to Health Care Practitioners (HCPs)
CDXC

Business Wire

5 months ago

ChromaDex Launches Niagen+ NAD+ Test Kit Available Exclusively to Health Care Practitioners (HCPs)

ChromaDex Appoints Carlos Lopez as Senior Vice President, General Counsel
CDXC

Business Wire

5 months ago

ChromaDex Appoints Carlos Lopez as Senior Vice President, General Counsel

ChromaDex Announces Pharmaceutical-Grade Intravenous and Injectable Niagen® Will Debut at Leading Wellness Clinics in August
CDXC

Business Wire

6 months ago

ChromaDex Announces Pharmaceutical-Grade Intravenous and Injectable Niagen® Will Debut at Leading Wellness Clinics in August

When Will ChromaDex Corporation (NASDAQ:CDXC) Turn A Profit?
CDXC

Simply Wall St.

6 months ago

When Will ChromaDex Corporation (NASDAQ:CDXC) Turn A Profit?

CDXC

MT Newswires

6 months ago

ChromaDex Joins Russell 2000 Index

ChromaDex to Join Russell 2000® Index
CDXC

Business Wire

6 months ago

ChromaDex to Join Russell 2000® Index

CDXC

MT Newswires

6 months ago

ChromaDex Chief Financial Officer Brianna Gerber to Resign

CDXC

MT Newswires

6 months ago

ChromaDex Says Nicotinamide Riboside Shows 'Promising Effects' in Peripheral Artery Disease Trial

Milestone Phase II Clinical Study Demonstrates Niagen®, Patented Nicotinamide Riboside (NR), Improves Functional Mobility for Individuals with Peripheral Artery Disease (PAD)
CDXC

Business Wire

6 months ago

Milestone Phase II Clinical Study Demonstrates Niagen®, Patented Nicotinamide Riboside (NR), Improves Functional Mobility for Individuals with Peripheral Artery Disease (PAD)

Here's Why We Think ChromaDex Corporation's (NASDAQ:CDXC) CEO Compensation Looks Fair
CDXC

Simply Wall St.

7 months ago

Here's Why We Think ChromaDex Corporation's (NASDAQ:CDXC) CEO Compensation Looks Fair

ChromaDex to Launch Niagen+, the First-Of-Its-Kind Pharmaceutical-Grade Intravenous and Injectable Niagen® (Patented Nicotinamide Riboside Chloride or NRC)
CDXC

Business Wire

7 months ago

ChromaDex to Launch Niagen+, the First-Of-Its-Kind Pharmaceutical-Grade Intravenous and Injectable Niagen® (Patented Nicotinamide Riboside Chloride or NRC)

ChromaDex (CDXC) Up as Ataxia Candidate Gets Orphan Drug Tag
CDXC

Zacks

7 months ago

ChromaDex (CDXC) Up as Ataxia Candidate Gets Orphan Drug Tag

CDXC

MT Newswires

7 months ago

ChromaDex Says US FDA Grants NRC Orphan Drug, Rare Pediatric Disease Designations -- Shares Climb Pre-Bell

ChromaDex Receives Exclusive U.S. FDA Orphan Drug Designation (ODD) and Rare Pediatric (RPD) Disease Designation for Nicotinamide Riboside Chloride (NRC) for the Treatment of Ataxia Telangiectasia (AT)
CDXC

Business Wire

7 months ago

ChromaDex Receives Exclusive U.S. FDA Orphan Drug Designation (ODD) and Rare Pediatric (RPD) Disease Designation for Nicotinamide Riboside Chloride (NRC) for the Treatment of Ataxia Telangiectasia (AT)

ChromaDex to Participate in Renmark’s Virtual Non-Deal Roadshow on Tuesday, June 11, 2024
CDXC

Business Wire

7 months ago

ChromaDex to Participate in Renmark’s Virtual Non-Deal Roadshow on Tuesday, June 11, 2024

ChromaDex (NASDAQ:CDXC) shareholders are still up 82% over 1 year despite pulling back 12% in the past week
CDXC

Simply Wall St.

7 months ago

ChromaDex (NASDAQ:CDXC) shareholders are still up 82% over 1 year despite pulling back 12% in the past week

ChromaDex to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024
CDXC

Business Wire

7 months ago

ChromaDex to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024

ChromaDex’s Niagen® Wins Prestigious NutraIngredients EU Healthy Ageing Ingredient of the Year Award
CDXC

Business Wire

7 months ago

ChromaDex’s Niagen® Wins Prestigious NutraIngredients EU Healthy Ageing Ingredient of the Year Award

ChromaDex Corp (CDXC) Q1 2024 Earnings: Aligns with EPS Projections, Misses Revenue Estimates
CDXC

GuruFocus.com

8 months ago

ChromaDex Corp (CDXC) Q1 2024 Earnings: Aligns with EPS Projections, Misses Revenue Estimates

ChromaDex Corporation (NASDAQ:CDXC) Q1 2024 Earnings Call Transcript
CDXC

Insider Monkey

8 months ago

ChromaDex Corporation (NASDAQ:CDXC) Q1 2024 Earnings Call Transcript

CDXC

Thomson Reuters StreetEvents

8 months ago

Q1 2024 Chromadex Corp Earnings Call

CDXC

GuruFocus.com

8 months ago

ChromaDex Corp (CDXC) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges and ...

CDXC

Associated Press Finance

8 months ago

ChromaDex: Q1 Earnings Snapshot

ChromaDex Corporation Reports First Quarter 2024 Financial Results
CDXC

Business Wire

8 months ago

ChromaDex Corporation Reports First Quarter 2024 Financial Results

An Intrinsic Calculation For ChromaDex Corporation (NASDAQ:CDXC) Suggests It's 43% Undervalued
CDXC

Simply Wall St.

8 months ago

An Intrinsic Calculation For ChromaDex Corporation (NASDAQ:CDXC) Suggests It's 43% Undervalued

ChromaDex’s NIAGEN® (Patented Nicotinamide Riboside, NR), the Most Efficient and High-Quality NAD+ Precursor, Featured in New Solgar® Cellular Nutrition Cellular Energy Supplement
CDXC

Business Wire

8 months ago

ChromaDex’s NIAGEN® (Patented Nicotinamide Riboside, NR), the Most Efficient and High-Quality NAD+ Precursor, Featured in New Solgar® Cellular Nutrition Cellular Energy Supplement

ChromaDex Announces Nationwide Launch of Tru Niagen® at The Vitamin Shoppe®
CDXC

Business Wire

8 months ago

ChromaDex Announces Nationwide Launch of Tru Niagen® at The Vitamin Shoppe®

ChromaDex to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024
CDXC

Business Wire

8 months ago

ChromaDex to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024

ChromaDex Announces Inaugural Major Grocery Debut of Tru Niagen® at Sprouts Farmers Market
CDXC

Business Wire

8 months ago

ChromaDex Announces Inaugural Major Grocery Debut of Tru Niagen® at Sprouts Farmers Market

Should You Think About Buying ChromaDex Corporation (NASDAQ:CDXC) Now?
CDXC

Simply Wall St.

9 months ago

Should You Think About Buying ChromaDex Corporation (NASDAQ:CDXC) Now?

Precision BioSciences (DTIL) Soars 13.4%: Is Further Upside Left in the Stock?
CDXC

Zacks

9 months ago

Precision BioSciences (DTIL) Soars 13.4%: Is Further Upside Left in the Stock?

ChromaDex Announces Tru Niagen® is Now Third-Party Verified Through the Alkemist Assured™ Transparency Program
CDXC

Business Wire

9 months ago

ChromaDex Announces Tru Niagen® is Now Third-Party Verified Through the Alkemist Assured™ Transparency Program

ChromaDex Full Year 2023 Earnings: EPS Beats Expectations
CDXC

Simply Wall St.

10 months ago

ChromaDex Full Year 2023 Earnings: EPS Beats Expectations

ChromaDex Corp (CDXC) Reports Encouraging Fiscal Year 2023 Results with Positive Adjusted EBITDA
CDXC

GuruFocus.com

10 months ago

ChromaDex Corp (CDXC) Reports Encouraging Fiscal Year 2023 Results with Positive Adjusted EBITDA

ChromaDex Corporation (NASDAQ:CDXC) Q4 2023 Earnings Call Transcript
CDXC

Insider Monkey

10 months ago

ChromaDex Corporation (NASDAQ:CDXC) Q4 2023 Earnings Call Transcript

CDXC

Thomson Reuters StreetEvents

10 months ago

Q4 2023 Chromadex Corp Earnings Call

ChromaDex Corporation Reports Fourth Quarter and Fiscal Year 2023 Results
CDXC

Business Wire

10 months ago

ChromaDex Corporation Reports Fourth Quarter and Fiscal Year 2023 Results

Insiders own 26% of ChromaDex Corporation (NASDAQ:CDXC) shares but retail investors control 44% of the company
CDXC

Simply Wall St.

10 months ago

Insiders own 26% of ChromaDex Corporation (NASDAQ:CDXC) shares but retail investors control 44% of the company

ChromaDex to Report Fourth Quarter 2023 Financial Results on Wednesday, March 6, 2024
CDXC

Business Wire

10 months ago

ChromaDex to Report Fourth Quarter 2023 Financial Results on Wednesday, March 6, 2024

ChromaDex to Participate in Renmark’s Virtual Non-Deal Roadshow on Monday, February 12, 2024
CDXC

Business Wire

a year ago

ChromaDex to Participate in Renmark’s Virtual Non-Deal Roadshow on Monday, February 12, 2024

Q3 Rundown: Best Buy Co (NYSE:BBY) Vs Other Specialty Retail Stocks
CDXC

StockStory

a year ago

Q3 Rundown: Best Buy Co (NYSE:BBY) Vs Other Specialty Retail Stocks

ChromaDex to Present at the Lytham Partners 2024 Investor Select Conference
CDXC

Business Wire

a year ago

ChromaDex to Present at the Lytham Partners 2024 Investor Select Conference

CDXC

Business Wire

a year ago

AMTD Digital’s Entertainment and Movie Businesses Are Estimated to Contribute Significantly to Net Profit

Chuck Royce Adds Northwest Pipe Co to Portfolio in Recent Trade
CDXC

GuruFocus.com

a year ago

Chuck Royce Adds Northwest Pipe Co to Portfolio in Recent Trade

CDXC

Business Wire

a year ago

AMTD Digital’s Half Yearly Net Profit is Estimated to Increase over 150% Year over Year

Charles Schwab Boosts Its Online Brokerage With Big TD Ameritrade Deal
CDXC

Investor's Business Daily

a year ago

Charles Schwab Boosts Its Online Brokerage With Big TD Ameritrade Deal

CDXC

Thomson Reuters StreetEvents

a year ago

Q4 2023 Sterling Bancorp Inc Earnings Call

CDXC

GuruFocus.com

a year ago

Sterling Bancorp Inc (SBT) Reports Improved Earnings for Q4 and Full Year 2023

Flexsteel Industries (FLXS) Just Flashed Golden Cross Signal: Do You Buy?
CDXC

Zacks

a year ago

Flexsteel Industries (FLXS) Just Flashed Golden Cross Signal: Do You Buy?

CDXC

Associated Press Finance

a year ago

Sterling Bancorp: Q4 Earnings Snapshot

Sterling Bancorp Reports Fourth Quarter and Full Year 2023 Financial Results
CDXC

Business Wire

a year ago

Sterling Bancorp Reports Fourth Quarter and Full Year 2023 Financial Results

Virtus Diversified Income & Convertible Fund Discloses Sources of Distribution – Section 19(a) Notice
CDXC

Business Wire

a year ago

Virtus Diversified Income & Convertible Fund Discloses Sources of Distribution – Section 19(a) Notice

Share on Social Networks: